Effect of pre-operative doses of betamethasone acetate 0.1% on control of eye inflammation and pain after cataract surgery.

Comparing the effect of pre-operative doses of betamethasone acetate 0.1% and placebo on control of eye inflammation and pain after cataract surgery in patients who undergo phacoemulsification surgery.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180606039989N1

Enrollment

Registered

2018-07-27

Start date

2017-03-21

Completion date

Unknown

Last updated

2018-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

senile cataract. senile cataract

Interventions

Intervention 1: Intervention group: administering betamethasone 0.1% eye drop 3 days prior to surgery 4 times a day, one drop each time. Intervention 2: Control group: administering normal saline 0.9%

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patient with senile cataract which needed surgery

Exclusion criteria

Exclusion criteria: Patient with significant superfacial eye disease. Patient with systemic rheumatologic disease. Diabetic patient. Use of medicines which cause dry eye. History of long term use of topical eye drops like glaucoma medicines.

Design outcomes

Primary

Measure	Time frame
Cell & Flare. Timepoint: before intervention, 1, 7, 30 days after intervention. Method of measurement: slit lamp biomicroscopy.;Ocular pain score. Timepoint: Before intervention, 1, 7, 30 days after intervention. Method of measurement: Ocular pain score in Visual Analogue Scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Zare Malek Abad

Mashhad University of Medical Sciences

Zaremf891@mums.ac.ir+98 51 3257 1467

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026